FORBES-TATE for EMERGENT BIOSOLUTIONS
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
National Defense Authorization Act (NDAA) for FY22, provisions related to biological and chemical defense and access to naloxone; S. 4231 (116th Congress) - Preparing for the Next Pandemic Act; Issues regarding opioid and heroin addiction legislation, naloxone access and awareness, and opioid prescribing guidelines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| JERRY DRISCOLL | — |
| KRISTINA DUNKLIN | — |
| ELIZABETH GREER | — |
| FRANCESCA MCCRARY | — |
| RICK MURPHY | — |
| EDWARD C. RENO | — |
| JEFFREY SADOSKY | — |
| WESLEY RYAN WELCH | — |
| DERRICK M WHITE | — |
| ZACHARY WILLIAMS | — |
Budget/Appropriations BUD
Issues regarding State Opioid Response Grant funding; Issues regarding Substance Abuse and Mental Health Block Grant funding; S. 987 - Comprehensive Addiction and Recovery Act (CARA) 3.0; H.R. 2379 -State Opioid Response Grant Authorization Act of 2021; Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder, including S. 166/H.R. 706 - Emergency Support for Substance Use Disorders Act; Issues regarding FY22 appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| JERRY DRISCOLL | — |
| KRISTINA DUNKLIN | — |
| ELIZABETH GREER | — |
| FRANCESCA MCCRARY | — |
| RICK MURPHY | — |
| EDWARD C. RENO | — |
| JEFFREY SADOSKY | — |
| WESLEY RYAN WELCH | — |
| DERRICK M WHITE | — |
| ZACHARY WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.